How can we help?

Search

€36 million awarded to a further six ground-breaking projects under DTIF Call 7

DTIF funding awarded to quantum, advanced manufacturing and MedTech projects

 

Minister for Enterprise, Tourism and Employment Peter Burke, and Minister for Further and Higher Education, Research, Innovation and Science, James Lawless today announced funding of €36.9 million for six additional projects under Call 7 of the Disruptive Technologies Innovation Fund (DTIF).

 

Six new projects were awarded amounts ranging from €1.7m to €13.7m for projects that span critical sectors including ICT, healthcare and advanced manufacturing. These awards reflect the Government’s continued commitment to fostering innovation and collaboration between SMEs, multinationals, and research institutions.

 

Announcing today’s projects, the Minister for Enterprise, Tourism and Employment, Peter Burke said:

“This further €36.9 million investment in six pioneering projects under the Disruptive Technologies Innovation Fund is a clear signal of the Governments continued support for bold, forward-thinking research and innovation.

 

“These six projects demonstrate the power of disruptive technologies to solve real-world challenges—from improving patient outcomes to advancing quantum technologies, revolutionising logistics and reducing energy consumption. These projects not only drive cutting-edge R&D within industry, but also support high-value jobs and the development of transformative technologies that will improve productivity and increase competitiveness."

 

James Lawless, Minister for Further and Higher Education, Research, Innovation and Science added: 

"The Disruptive Technologies Innovation Fund is playing a pivotal role in advancing the knowledge economy by fostering transformative collaborations between academia and industry. This funding is empowering companies and research institutions nationwide to attract top-tier graduates to work on cutting-edge technologies. It’s also creating a vibrant pipeline of opportunities for research graduates – whether through direct employment or the development of spin-out ventures."

 

Jenny Melia, CEO, Enterprise Ireland, said:

“The latest tranche of DTIF funding is an important solution for Enterprise Ireland clients in supporting them to transform and underpin their ability to scale, extend their global reach and create high quality jobs. It is exciting to see high potential start-ups (HPSUs) leading the development of disruptive technologies in areas such as transport logistics and quantum computing, and collaborating with established multinational companies and research institutions.“

 

DTIF Call 7 closed on 30 April 2025, and the remaining applications received are currently undergoing evaluation.

 

Note to Editors

 

The Disruptive Technologies Innovation Fund (DTIF) is a €500 million fund established under the National Development Plan (NDP) in 2018. The Department of Enterprise, Tourism and Employment manages the DTIF with administrative support from Enterprise Ireland.

 

The purpose of the Fund is to drive collaboration between Ireland’s world-class research base and industry, as well as facilitating enterprises to compete directly for funding in support of the development and adoption of these technologies. The aim is to support investment in the development and deployment of disruptive technologies and applications on a commercial basis.

 

DTIF Call 7 applications are assessed by panels of international experts against four criteria – quality of the disruptive technology, excellence of overall approach, economic impact and sustainability, and strength of the collaboration. Of the €36.9m funding being announced today, approximately €17.5m will be going to project partners outside of Dublin.

 

Prospective applicants can obtain detailed information on the Fund and on the application process through enterprise.gov.ie/DTIF

 

Project Description

 

Consortium Members

 

Research Priority Area

 

Regional Location

 

Total DTIF Award

 

 

 

QUBIC – will create quantum algorithms, hardware, and software to develop quantum-enabled solutions for Ireland’s key challenges in energy, climate modelling, advanced materials, and pharmaceuticals.

 

 

  • Equal 1 Laboratories Ireland Ltd
  • Biosimulytics Ltd
  • Nexalus Ltd
  • Algorithmiq Computing Ltd5.
  • Dell Technologies
  • Irish Manufacturing Research Centre (IMR)
  • CeADAR  - Ireland’s National AI Centre (UCD)

 

 

ICT

 

 

Dublin, Cork, Westmeath 

 

 

€13.7m

 

 

SensABLATE – will collaborate to develop ablation, shape-sensing and tissue sensing technologies which will enable the removal or destruction of unwanted tissue in the body – such as tumours or areas causing irregular heartbeats – without major surgery.

 

 

  • Endowave Ltd
  • Quadrant Scientific Ltd
  • Atlantic Technological University
  • Tyndall National Institute

 

 

Health & Wellbeing

 

 

Galway & Cork 

 

 

€11.1m

 

 

BioDesign – development of a machine learning- and AI-powered platform that will help create and study protein-like enzymes and antibodies to support better treatments and health outcomes.

 

 

  • Neogen Corporation, T/A Megazyme Ltd
  • Novus Diagnostics Ltd
  • National Institute of Bioprocessing Research and Training (NIBRT)

 

 

Health & Wellbeing 

 

 

Dublin & Wicklow 

 

 

€4.1m

 

 

LIFT – Transport project, which will address the inhibiting problem of poor scalability of advanced composite manufacturing will review materials and production techniques to optimise drone performance and deliver a fully integrated, end-to-end solution tailored for logistics operators to adopt drone delivery at scale.

 

 

  • IONA Logistics Ltd
  • ÉireComposites Teo
  • Technological University Dublin

 

 

Manufacturing & Materials 

 

 

Dublin, Galway & Clare 

 

 

€3.8m

 

 

NAIRA – Native AI for energy efficient and sustainable Radio Access networks. Will address the key issue of reducing energy consumption in mobile networks.

 

 

 

  • Trinity College Dublin 
  • Software Radio Systems Ltd
  • Intel Research and Development Ireland Ltd
  • Red Hat Ltd
  • Dell Technologies
  • Tyndall National Institute

 

 

ICT

 

 

Dublin & Cork 

 

 

€2.5m

 

 

Spiorad – working together to develop a vascular closure device (VCD) that will stop bleeding quickly and safely during procedures, such as angiograms, that use larger tubes or devices to access the body.

 

 

 

  • Spiorad Medical Ltd
  • Dolmen Design and Innovation Ltd
  • University of Galway (UG)

 

 

Health & Wellbeing 

 

 

Galway & Dublin 

 

 

€1.7m

 

 

ENDS

 

For further information, please contact Press Office, Department of Enterprise, Tourism and Employment, press.office@enterprise.gov.ie or (01) 631-2200

© 2025 Enterprise Ireland All rights reserved
VAT No: IE9590828H